UNIS-BIO PHARMA LLC – FDA Inspection, Feb 17, 2026

Record Details

This FDA Inspection record concerns UNIS-BIO PHARMA LLC, with an inspection on February 17, 2026, issued by the Dallas District Office, covering foods & cosmetics.

Company: UNIS-BIO PHARMA LLC
Inspection Date: February 17, 2026
Product Type: Foods & Cosmetics
Office: Dallas District Office
People: Verlin J. Herbert (Issuing Officer)
Vitaliy N. Guyvan (Issuing Officer)

View Company Profile

ID · 37b2e21b-e536-400d-a0a6-c6d2fa961e3f

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1303426
FDA center: Foods & Cosmetics
Project area: Food Composition, Standards, Labeling, and Economics
Outcome: Form 483 issued

FDA Citations

21 CFR 111.70(f)Specifications - product received for packaging, labeling
21 CFR 111.205(a)Master manufacturing record - prepared
21 CFR 111.255(a)Batch record - every batch

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore UNIS-BIO PHARMA LLC

FDA Inspection

UNIS-BIO PHARMA LLCFebruary 17, 2026